Search

everythinglearnresearchcommunity

for

Search:↓

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Acyzol could help treat conditions caused by zinc deficiency.

Vitamin D is important for skin health, but more research is needed to understand its full effects and treatment potential.

Certain gene variations and different levels of BDNF and CRH hormones are linked to vitiligo.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

The congress showed advancements in skin hydration, barrier function, and safe, effective new cosmetic formulations.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Narrowband UVB treatment increases certain gene expressions in psoriasis skin and improves symptoms.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Narrowband Ultraviolet B treatment can significantly reduce anxiety in psoriasis patients, but it doesn't significantly affect depression.

A shampoo with cannabidiol can significantly reduce scalp inflammation and symptoms in people with mild to moderate psoriasis or seborrheic dermatitis.

Fungal skin infections significantly lower patients' quality of life.

The Thai version of the Family Dermatology Life Quality Index is a reliable and valid tool for assessing the quality of life of patients' families.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.